Algo version: 0.98b
Idogen AB (publ) is listed at the STO Exchange
Idogen AB (publ) [IDOGEN.ST]
STO Sector: Healthcare Industry:Biotechnology

Is Idogen AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Idogen AB (publ) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK14.88, you would have made a loss of SEK-14.76 per share or -99.19%

We do not have enough data to give you this answer.

Idogen AB (publ) has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Idogen AB (publ) to be medium [0.6 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.